Drugs / CB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02866331 | Jul 2016 → Dec 2018 | cerebral palsy | Hanyang University Seoul Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02866331 ↗ |
| Modality | Cell therapy | “autologous cord blood mononuclear cells (CB)” NCT02866331 ↗ |